Engineered regulatory T (T reg ) cells have emerged as precision therapeutics aimed at inducing immune tolerance while reducing the risks associated with generalized immunosuppression. This Viewpoint highlights the opportunities and challenges for engineered T reg cell therapies in treating autoimmune and other inflammatory diseases.

中文翻译：

---

利用调节性 T 细胞建立免疫耐受

工程监管 T (T注册）细胞已成为精准疗法，旨在诱导免疫耐受，同时降低与全身免疫抑制相关的风险。这一观点强调了工程 T 的机遇和挑战注册细胞疗法治疗自身免疫性疾病和其他炎症性疾病。